Gonadorelin

• MEDAM (Menopur Retrospective Data prograM)
  Unknown Phase COMPLETED Ferring Pharmaceuticals
• CIRCULATING MICRO-RNA (miRNA) AND AR-V7 MUTATIONAL STATUS IN METASTATIC CASTRATION-RESISTANT PROSTATE CANCER (CRPC): PRIMERA+ STUDY (PROSTATE CANCER INNOVATING MARKERS OF EXPECTED RESPONSE TO AGONIST LHRH+ ANDROGEN RECEPTOR INHIBITION
  Unknown Phase UNKNOWN Azienda Ospedaliero-Universitaria Careggi
• Role of Ratio of Progesterone to Number of Follicles as a Prognostic Tool for IntracytoplasmicSperm Injection Outcome
  Unknown Phase UNKNOWN Ain Shams Maternity Hospital
• A Study to Explore Correlation Between Symptoms and Signs of Polycystic Ovarian Syndrome (PCOS) and Risk of Over-response to Ovarian Stimulation
  Unknown Phase COMPLETED Merck KGaA, Darmstadt, Germany
• TSH And AMH in Infertile Women
  Unknown Phase UNKNOWN Ain Shams Maternity Hospital

Showing 5 of 61 trials.

• Nationwide Survey of Institutional Factors Related to the Use of Gonadotropin-Releasing Hormone Analogs for Ovarian Protection in Women Receiving Chemotherapy in Japan.
  J Obstet Gynaecol Res unknown
• Protocol flexibility in PCOS: a combination of controlled ovarian stimulation and endometrial preparation strategies shows no impact on live birth outcomes after frozen embryo transfer-a retrospective cohort study.
  Gynecol Endocrinol unknown
• Effect of GnRH administration on egg production, hormonal and biochemical profile and ovarian histomorphology of spent naked neck layers.
  Poult Sci unknown
• THE GONADOTROPIN RELEASING HORMONE AGONIST, DESLORELIN ACETATE, IS CONTRAINDICATED FOR MITIGATION OF AGGRESSION AND REPRODUCTIVE BEHAVIOR IN MALE COWNOSE RAYS (RHINOPTERA BONASUS).
  J Zoo Wildl Med unknown
• An explainable machine learning model for identifying the risk of suboptimal oocyte maturation in patients with polycystic ovary syndrome undergoing GnRH-antagonist protocol.
  J Ovarian Res unknown

Showing 5 of 20 papers by citation count.

FDA Data

Frequently Asked Questions